Terms: = Prostate cancer AND MLLT11, Q13015, 10962, ENSG00000213190, AF1Q AND Diagnosis
1 results:
1. Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer.
Lin J; Cai Y; Wang Z; Ma Y; Pan J; Liu Y; Zhao Z
Front Endocrinol (Lausanne); 2022; 13():1005916. PubMed ID: 36686485
[TBL] [Abstract] [Full Text] [Related]